COFG Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$680K Sell
739
-7
-0.9% -$7.1K 0.17% 89
2025
Q4
$802K Buy
+746
New +$713K 0.2% 81

Other funds holding LLY

COFG Advisors's LLY Position: Q1 2026 in Review

COFG Advisors reduced its Eli Lilly (LLY) stake by 0.94% in Q1 2026, selling an estimated $7.1K and leaving 739 shares worth $680K. The position accounts for 0.17% of the portfolio, ranked #89.

COFG Advisors first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $802K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • COFG Advisors held 739 shares of Eli Lilly worth $680K as of Q1 2026.
  • COFG Advisors sold 7 Eli Lilly shares in Q1 2026, an estimated $7.1K.
  • Eli Lilly made up 0.17% of COFG Advisors's portfolio in Q1 2026, its #89 holding.
  • COFG Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • COFG Advisors's Eli Lilly position peaked at $802K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on COFG Advisors's 13F filing for Q1 2026, filed 11 May 2026.